St James's University Hospital

Recent publications and citations

Top Concepts

Top subject area publications in last 5 years

Collaboration Analysis

Publications from 2021 to 2026

Latest Publications

Filter IconFilter

Showing 10 of 2,335 papers

  • Research Article

CALYPSO: Final Results of Savolitinib and Durvalumab Combination in Metastatic Papillary Renal Cancer.

  • Apr 20, 2026
  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • Francesca Jackson-Spence +21
  • Open Access
  • Research Article

Risk-stratified surveillance for individuals in the UK at high risk of developing pancreatic cancer: Outcomes from the European Registry of Hereditary Pancreatic Diseases (EUROPAC).

  • Mar 01, 2026
  • European journal of cancer (Oxford, England : 1990)
  • Phillip J Hopley +20
  • Research Article

Natural history of HIV

  • Mar 01, 2026
  • Medicine
  • Alison Cox +1
  • Research Article

Operationalising Genomic Surveillance for Antimicrobial Resistance in Low- and Middle-Income Countries: A One Health Perspective from Bangladesh.

  • Feb 25, 2026
  • Microorganisms
  • Khushal Singh +1
  • Open Access
  • Research Article

The perioperative microbiome of patients undergoing rectal cancer surgery: A pilot study

  • Feb 01, 2026
  • Colorectal Disease
  • Kiedo Wienholts +10
  • Open Access
  • Research Article
  • Citations1

PIEZO1 channel mechanosensing in hepatobiliary physiology and disease.

  • Feb 01, 2026
  • American journal of physiology. Cell physiology
  • Charalampos Konstantinou +11
  • Open Access
  • Research Article

Treatment planning for lung cancer reirradiation accounting for previously delivered dose☆

  • Feb 01, 2026
  • Physics and Imaging in Radiation Oncology
  • David P Walton +11
  • Open Access
  • Research Article

BAFF-R Expression as a Potential Biomarker Associated with COVID-19 Vaccine Non-Responsiveness in Antibody-Deficient Patients.

  • Jan 20, 2026
  • Clinical and experimental immunology
  • Eleanor O'callaghan +8
  • Research Article

CRUK: Phase II trial of ginisortamab with (1) 1st-line gemcitabine + nab-paclitaxel (AG) or (2) MEK inhibitor as maintenance therapy in patients (pts) with metastatic pancreatic ductal adenocarcinoma (mPDAC).

  • Jan 10, 2026
  • Journal of Clinical Oncology
  • T.r Jeffry Evans +19
  • Research Article

435 Impact of MRI on Real-World Staging Pathways and Management Timelines in Pancreatic Cancer: A Systematic Review

  • Dec 29, 2025
  • British Journal of Surgery
  • Mohammed Memon +6
Cactus Communications logo

Copyright 2026 Cactus Communications. All rights reserved.